| Friday, January 03, 2003 |
| 12:00:00 PM |
Dr. B.J. Fowlkes, NIAID |
Bldg 426 Conf. Rm |
| |
Lineage Commitment in Developing T Cells
|
Details
Series
|
|
| 12:00:00 PM |
Dhara N. Amin, Yale School of Medicine |
Bldg 539, Rm 126D |
| |
Gene Expression Profiling Reveals Receptor and Ligand Dependent Specificity within the ErbB Receptor Family
|
Details
|
| Monday, January 06, 2003 |
| 1:00:00 PM |
Dr. Wei Wang |
Bldg 549 Auditorium |
| |
Novel Strategies for the Development of Peptide and Peptidomimetic-based Drugs
|
Details
|
|
| 2:00:00 PM |
Hong Zhang, PhD, The Wistar Institute |
Bldg 426 Conf. Rm |
| |
IGF-I induced IRS-1
|
Details
|
| Tuesday, January 07, 2003 |
| 3:30:00 PM |
Dr. Carl Mann, Services de Biochimie et de Genetique Moleculaire |
Bldg 549 Auditorium |
| |
Regulators and Effectors of the Rad53 DNA Damage Checkpoints in Yeast
|
Details
|
|
| 4:00:00 PM |
Harvey Alter & Jake Liang |
Bldg 549 Conf. Rm B |
| |
Hepatitis C: Virus and Infection
|
Details
|
| Wednesday, January 08, 2003 |
| 9:00:00 AM |
Dr. Charles Tyson, SRI International |
Bldg 549 Auditorium |
| |
In vitro Systems to Predict Hepatobiliary Toxicity
|
Details
Series
|
| Monday, January 13, 2003 |
| 2:00:00 PM |
David M. Frucht, MD, FDA, Division of Monoclonal Antibodies |
Bldg 426 Conf. Rm |
| |
The role of Thl-Associated Transcription Factors in the Function of Antigen Presenting Cells
|
Details
|
| Tuesday, January 14, 2003 |
| 2:00:00 PM |
Julia Ann Dolan, Bureau of Alcohol, Tobacco and Firearms |
Bldg 549 Auditorium |
| |
Applications of Mass Spectromety to Forensic Science: Analysis of Evidence from Arson and Explosive Incidents
|
Details
Series
|
| Wednesday, January 15, 2003 |
| 12:00:00 PM |
Steve Hughes, NCI/Retroviral Replication Lab |
Bldg 549 Auditorium |
| |
HIV-1 Reverse Transcriptase: Mechanisms of Nucleotide Analog Resistance
|
Details
Series
|
| Thursday, January 16, 2003 |
| 12:00:00 PM |
Dr. Matthew Kelley, NIDCD |
Bldg 539 Library |
| |
Development of Planar Cell Polarity in the Mammalian Cochlea
|
Details
|
|
| 12:00:00 PM |
Kevin L. Gardner, MD, PhD,NCI/Lab of Pathology |
Bldg 549 Auditorium |
| |
Novel Transcriptional Approaches to Studying Molecular Signaling In Activated T-Cells
|
Details
|
|
| 12:00:00 PM |
McRae Joseph Smith, PhD, CelTor Biosystem |
Bldg 549 Conf. Rm B |
| |
Leukocyte Adhesion: From Molecular Kinetics to High Throughput Screening: It's a Sticky Business
|
Details
|
| Friday, January 17, 2003 |
| 11:00:00 AM |
Grigori Enikolopov, PhD, Cold Spring Harbor Lab |
Bldg 549 Auditorium |
| |
Nitric Oxide, Cell Differentiation, and Organism Development
|
Details
|
|
| 12:00:00 PM |
Dr. Mary Carrington, SAIC-Frederick |
Bldg 426 Conf. Rm |
| |
Genetic Effects of KIR Genes in Human Disease
|
Details
Series
|
|
| 12:00:00 PM |
Demirkan B. Gursel, PhD, University of Bordeaux |
Bldg 539 Library |
| |
The Role of Fibroblast Growth Factor/Fibroblast Growth Factor Receptor (FGF/FGFR) Activity in Tumor Growth and Angiogenesis
|
Details
|
| Tuesday, January 21, 2003 |
| 1:00:00 PM |
Dr. Katherine Seley, Georgia Institute of Technology |
Bldg 549 Auditorium |
| |
Some Twists and Turns in a Tale of Drug Design
|
Details
|
|
| 2:00:00 PM |
John Michnowicz, Agilent Technologies |
Bldg 426 Conf. Rm |
| |
Recent Advances in Proteomics Technologies: Turning Data Into Information
|
Details
Series
|
| Wednesday, January 22, 2003 |
| 9:00:00 AM |
Dr. Ivan N. Rich, HemoGenix LLC |
Bldg 549 Auditorium |
| |
HALO-A High Throughput, Multifunctional Assay Platform for Hemotoxicity during Drug Development and Basic and Clinical Hematopoietic Research
|
Details
Series
|
|
| 12:00:00 PM |
Dr. Mohammed Amir Ashique, The Forsyth Institute |
Bldg 539, Rm 126D |
| |
Bone Morphogenetic Proteins (BMP) Signaling Molecules in Facial Morphogenesis and Dsymorphogenesis
|
Details
|
|
| 12:00:00 PM |
George Beck, NCI/Basic Research Lab |
Bldg 549 Auditorium |
| |
Osteopontin and Nrf2 Are Regulated by Inorganic Phosphate During Osteoblast Differentiation
|
Details
Series
|
| Thursday, January 23, 2003 |
| 1:00:00 PM |
Fugen Zhang, University of Maryland, Baltimore County |
Bldg 549 Conf. Rm A |
| |
(1)Mechanism of the Reactions Between Typical Flavonoids and Peroxyl Radicals, (2) Thiolytic Chemistry of Cancer Chemopreventive Effect of Oltipraz
|
Details
|
| Friday, January 24, 2003 |
| 12:00:00 PM |
Thomas Rogers, PhD, Temple University School of Medicine |
Bldg 426 Conf. Rm |
| |
A Painful Experience: Cross-talk Between Opioid and Chemokine Receptors
|
Details
Series
|
| Monday, January 27, 2003 |
| 1:00:00 PM |
Dr. Jeff Gildersleeve |
Bldg 549 Auditorium |
| |
New Strategies for the Directed Evolution of Biocatalysts
|
Details
|
| Tuesday, January 28, 2003 |
| 2:00:00 PM |
Chin-Kai Meng, Agilent Technologies |
Bldg 549 Auditorium |
| |
Electrospray and John Fenn, Nobel Laureate
|
Details
Series
|
| Wednesday, January 29, 2003 |
| 12:00:00 PM |
Dimiter Dimitrov, NCI/Lab of Experimental and Computational Biology |
Bldg 549 Auditorium |
| |
Novel Broadly HIV Neutralizing Human Monoclonal Antibodies
|
Details
Series
|
|
| 1:15:00 PM |
Dr. Thomas W. Kensler, Johns Hopkins School of Public Health |
Bldg 549 Auditorium |
| |
Molecular Regulation of Enzymes that Detoxify Carcinogens: Targets for Prevention
|
Details
Series
|
| Friday, January 31, 2003 |
| 12:00:00 PM |
Dr. Carole A. Parent, LCMB,NCI, NIH |
Bldg 426 Conf. Rm |
| |
"Chemotaxis: Leading From Behind"
|
Details
Series
|
|
| 2:00:00 PM |
Prof. Joel Sussman, Weizmann Institute of Science |
Bldg 549 Auditorium |
| |
Natively Unstructured Proteins: A Case Study of Cholinesterase-like Adhesion Molecules (CLAMs)
|
Details
|
